Department of Oncology, First Affiliated Hospital of University of South China, Hengyang 421001, PR China.
Int J Oncol. 2010 Nov;37(5):1345-52. doi: 10.3892/ijo_00000787.
5,7-dihydroxy-8-nitrochrysin (NOC), a novel synthetic chrysin analogue, induces apoptosis in human cancer cells. We previously demonstrated that NOC possesses stronger cytotoxicity towards human colon carcinoma and human gastric carcinoma cells than chrysin. Herein, we demonstrate the mechanism by which NOC preferentially suppresses the viability of the MDA-MB-453 human breast cancer cell line (ER negative, Her2 overexpressing) and moderately suppresses the viability of the MCF-7 cell line (ER positive, Her2 low), but has little effect on the immortalized non-cancerous HBL-100 breast cell line (ER positive, Her2 low). Moreover, the results of our studies, for the first time, provide mechanistic evidence that NOC induces apoptosis by the generation of reactive oxygen species and Akt dephosphorylation. Our findings highlight a new mechanism responsible for NOC-induced apoptosis, and raise the possibility that NOC might be promising as a candidate for human breast cancer therapy.
5,7-二羟基-8-硝基白杨素(NOC),一种新型的白杨素类似物,可诱导人类癌细胞凋亡。我们之前的研究表明,与白杨素相比,NOC 对人结肠癌细胞和人胃腺癌细胞具有更强的细胞毒性。在此,我们阐述了 NOC 优先抑制 MDA-MB-453 人乳腺癌细胞系(ER 阴性,Her2 过表达)活力,适度抑制 MCF-7 细胞系(ER 阳性,Her2 低表达)活力,而对永生化非癌细胞系 HBL-100(ER 阳性,Her2 低表达)几乎没有影响的机制。此外,我们的研究结果首次提供了 NOC 通过产生活性氧和 Akt 去磷酸化诱导细胞凋亡的机制证据。我们的发现强调了 NOC 诱导细胞凋亡的一种新机制,并提出了 NOC 可能作为人类乳腺癌治疗候选药物的可能性。